190 related articles for article (PubMed ID: 32622812)
1. Rapid scale-up and production of active-loaded PEGylated liposomes.
Roces CB; Port EC; Daskalakis NN; Watts JA; Aylott JW; Halbert GW; Perrie Y
Int J Pharm; 2020 Aug; 586():119566. PubMed ID: 32622812
[TBL] [Abstract][Full Text] [Related]
2. Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomes.
Webb C; Forbes N; Roces CB; Anderluzzi G; Lou G; Abraham S; Ingalls L; Marshall K; Leaver TJ; Watts JA; Aylott JW; Perrie Y
Int J Pharm; 2020 May; 582():119266. PubMed ID: 32251694
[TBL] [Abstract][Full Text] [Related]
3. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
Xiao P; Zhao J; Huang Y; Jin R; Tang Z; Wang P; Song X; Zhu H; Yang Z; Yu N
Pharm Nanotechnol; 2020; 8(5):391-398. PubMed ID: 32787769
[TBL] [Abstract][Full Text] [Related]
4. Effect of the concentration process on unloaded and doxorubicin loaded liposomal dispersions.
Perinelli DR; Cespi M; Rendina F; Bonacucina G; Palmieri GF
Int J Pharm; 2019 Apr; 560():385-393. PubMed ID: 30802548
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of supravesicular structures in doxorubicin-containing pegylated liposomes.
Milosevits G; Rozsnyay Z; Kozma GT; Milosevits J; Tömöry G; Robotka H; Rosivall L; Szebeni J
Chem Phys Lipids; 2012 May; 165(4):482-7. PubMed ID: 22206709
[TBL] [Abstract][Full Text] [Related]
6. Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs.
Schilt Y; Berman T; Wei X; Nativ-Roth E; Barenholz Y; Raviv U
Biochim Biophys Acta Gen Subj; 2021 May; 1865(5):129849. PubMed ID: 33460771
[TBL] [Abstract][Full Text] [Related]
7. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A
Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug.
Maiti K; Bhowmick S; Jain P; Zope M; Doshi K; Rajamannar T
Anticancer Agents Med Chem; 2018; 18(4):597-609. PubMed ID: 29173186
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
10. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
Yamamoto E; Miyazaki S; Aoyama C; Kato M
Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
[TBL] [Abstract][Full Text] [Related]
11. Effects of lipid composition on the properties of doxorubicin-loaded liposomes.
Sakai-Kato K; Nanjo K; Kawanishi T; Okuda H; Goda Y
Ther Deliv; 2015 Jul; 6(7):785-94. PubMed ID: 26228772
[TBL] [Abstract][Full Text] [Related]
12. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
13. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.
Yuan W; Kuai R; Dai Z; Yuan Y; Zheng N; Jiang W; Noble C; Hayes M; Szoka FC; Schwendeman A
AAPS J; 2017 Jan; 19(1):150-160. PubMed ID: 27485642
[TBL] [Abstract][Full Text] [Related]
14. Sterically stabilized liposomes production using staggered herringbone micromixer: Effect of lipid composition and PEG-lipid content.
Cheung CCL; Al-Jamal WT
Int J Pharm; 2019 Jul; 566():687-696. PubMed ID: 31212051
[TBL] [Abstract][Full Text] [Related]
15. An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome.
Wibroe PP; Ahmadvand D; Oghabian MA; Yaghmur A; Moghimi SM
J Control Release; 2016 Jan; 221():1-8. PubMed ID: 26608877
[TBL] [Abstract][Full Text] [Related]
16. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
[TBL] [Abstract][Full Text] [Related]
17. Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory.
Lin W; Li A; Qiu L; Huang H; Cui P; Wang J
Mol Pharm; 2024 Jun; 21(6):2970-2980. PubMed ID: 38742943
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetration.
Dong YD; Tchung E; Nowell C; Kaga S; Leong N; Mehta D; Kaminskas LM; Boyd BJ
J Liposome Res; 2019 Mar; 29(1):1-9. PubMed ID: 29020849
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterizations of PEGylated liposomal doxorubicin.
Jiang W; Lionberger R; Yu LX
Bioanalysis; 2011 Feb; 3(3):333-44. PubMed ID: 21320053
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
Gkionis L; Aojula H; Harris LK; Tirella A
Int J Pharm; 2021 Jul; 604():120711. PubMed ID: 34015381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
